Looking to diversify beyond KURE.L? The ETFs below have the lowest correlation with KURE.L — they tend to move on their own, which can help reduce risk when the rest of your portfolio drops. The stock ideas table highlights individual companies that behave independently from KURE.L.
Best Diversifiers for KURE.L
1 ETFs have low correlation with KURE.L (below 0.3), 0 of which are negatively correlated. The least correlated is Global X Genomics & Biotechnology UCITS ETF (GNOG.L) (Health & Biotech Equities) with a 1Y correlation of 0.29, roughly unchanged from 0.30 over 5 years.
| Symbol | Name | Correlation 1Y | Correlation 3Y | Correlation 5Y | Risk / Return Rank | Category | Compare |
|---|---|---|---|---|---|---|---|
| Global X Genomics & Biotechnology UCITS ETF | 0.29 | 0.30 | 0.30 | 62 | Health & Biotech Equities | KURE.L vs GNOG.L | |
| Invesco Nasdaq Biotech UCITS ETF | 0.30 | 0.30 | 0.30 | 72 | Health & Biotech Equities | KURE.L vs SBIO.L | |
| First Trust NYSE Arca Biotechnology UCITS ETF Acc | 0.31 | 0.32 | 0.32 | 56 | Health & Biotech Equities | KURE.L vs FBT.L | |
| WisdomTree BioRevolution UCITS ETF USD Acc | 0.31 | 0.32 | 0.32 | 61 | Health & Biotech Equities | KURE.L vs WBIO.L | |
| iShares Nasdaq US Biotechnology UCITS ETF | 0.32 | — | — | 76 | Health & Biotech Equities | KURE.L vs BTEK.L |
See all 6 diversifiers for KURE.L
To view more results, upgrade your current subscription plan.
Diversification Analysis
Build a portfolio that complements KURE.L
Add KURE.L to the Diversification Analyzer to see how it overlaps with your other holdings and which assets balance it best.
Analyze a portfolio with KURE.L